🇺🇸 FDA
Patent

US 11377451

Compositions and methods for treating cancer

granted A61PA61P35/00

Quick answer

US patent 11377451 (Compositions and methods for treating cancer) held by The Regents of the University of California expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P35/00